Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance

Purpose: The COVID-19 pandemic presents significant future health challenges. Its impact on pregnant women and their newborn is a particular area of concern. This study aims to examine the potential role of maternal immune activation (MIA), due to SARS-CoV-2 infection, on early neurodevelopment. Met...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexandre Díaz-Pons, Sergio Castaño-Castaño, Víctor Ortiz-García de la Foz, Ángel Yorca-Ruiz, Carlos Martínez-Asensi, Eva Munarriz-Cuezva, Rosa Ayesa-Arriola
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Brain, Behavior, & Immunity - Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666354625000146
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542454784458752
author Alexandre Díaz-Pons
Sergio Castaño-Castaño
Víctor Ortiz-García de la Foz
Ángel Yorca-Ruiz
Carlos Martínez-Asensi
Eva Munarriz-Cuezva
Rosa Ayesa-Arriola
author_facet Alexandre Díaz-Pons
Sergio Castaño-Castaño
Víctor Ortiz-García de la Foz
Ángel Yorca-Ruiz
Carlos Martínez-Asensi
Eva Munarriz-Cuezva
Rosa Ayesa-Arriola
author_sort Alexandre Díaz-Pons
collection DOAJ
description Purpose: The COVID-19 pandemic presents significant future health challenges. Its impact on pregnant women and their newborn is a particular area of concern. This study aims to examine the potential role of maternal immune activation (MIA), due to SARS-CoV-2 infection, on early neurodevelopment. Methods: We analysed 107 mother-infant dyads from the COGESTCOV-19 study in Cantabria, Spain, which included 59 SARS-CoV-2 exposed (cases) and 48 unexposed (controls) mothers, recruited between December 2020 and February 2022. Cytokine levels (IL-6 and IL-10) were obtained from maternal blood and cord blood. Neurodevelopment was assessed using the Neonatal Behavioral Assessment Scale (NBAS) at six weeks of age. Trimester of infection was considered in the main analyses. Results: Results showed no significant overall delays in early neurodevelopment due to maternal SARS-CoV-2 infection. Control infants performed better in some NBAS items. However, cases infants showed trimester-specific differences. First-trimester exposure was related to motor and reflex delays, second-trimester to poorer performances in motor tasks and autonomic stability, and third-trimester to weaker state organization, regulation, and reflexes. Some correlations between cytokine levels and NBAS performance showed moderate associations. Conclusions: These findings highlight the need for ongoing neurodevelopmental monitoring of infants born during the COVID-19 pandemic. The study enhances our understanding of MIA's impact on early development, emphasizing the importance of addressing homeostatic mechanisms in mothers and newborns.
format Article
id doaj-art-8408f304ade54153afb6feb64762c34a
institution Kabale University
issn 2666-3546
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Brain, Behavior, & Immunity - Health
spelling doaj-art-8408f304ade54153afb6feb64762c34a2025-02-04T04:10:36ZengElsevierBrain, Behavior, & Immunity - Health2666-35462025-03-0144100956Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balanceAlexandre Díaz-Pons0Sergio Castaño-Castaño1Víctor Ortiz-García de la Foz2Ángel Yorca-Ruiz3Carlos Martínez-Asensi4Eva Munarriz-Cuezva5Rosa Ayesa-Arriola6Departamento de Investigación en Enfermedades Mentales, Instituto de Investigación Marqués de Valdecilla (IDIVAL), 39011, Santander, Spain; Escuela de Doctorado de la Universidad de Cantabria (EDUC), Universidad de Cantabria (UC), 39005, Santander, Spain; Departamento de Medicina y Ciencias de la Salud, Facultad de Medicina, Universidad de Cantabria (UC), 39011, Santander, Spain; Facultad de Psicología, Universidad Nacional de Educación a Distancia (UNED), 28015, Madrid, SpainDepartamento de Psicobiología, Facultad de Psicología, Universidad de Oviedo (UO), 33003, Oviedo, Spain; Instituto de Neurociencias del Principado de Asturias (INEUROPA), 33003, Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, SpainDepartamento de Investigación en Enfermedades Mentales, Instituto de Investigación Marqués de Valdecilla (IDIVAL), 39011, Santander, SpainDepartamento de Investigación en Enfermedades Mentales, Instituto de Investigación Marqués de Valdecilla (IDIVAL), 39011, Santander, Spain; Escuela de Doctorado de la Universidad de Cantabria (EDUC), Universidad de Cantabria (UC), 39005, Santander, Spain; Departamento de Biología Molecular, Facultad de Medicina, Universidad de Cantabria (UC), 39011, Santander, SpainDepartamento de Investigación en Enfermedades Mentales, Instituto de Investigación Marqués de Valdecilla (IDIVAL), 39011, Santander, Spain; Facultad de Psicología, Universidad Nacional de Educación a Distancia (UNED), 28015, Madrid, SpainDepartamento de Farmacología, Facultad de Medicina y Enfermería, Universidad del País Vasco/ Euskal Herriko Unibertsitatea (UPV/EHU), 48940, Leioa, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, 28029, Madrid, SpainDepartamento de Investigación en Enfermedades Mentales, Instituto de Investigación Marqués de Valdecilla (IDIVAL), 39011, Santander, Spain; Departamento de Medicina y Ciencias de la Salud, Facultad de Medicina, Universidad de Cantabria (UC), 39011, Santander, Spain; Facultad de Psicología, Universidad Nacional de Educación a Distancia (UNED), 28015, Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, 28029, Madrid, Spain; Corresponding author. Departamento de Investigación en Enfermedades Mentales, Instituto de Investigación Marqués de Valdecilla (IDIVAL), 39011, Santander, Spain.Purpose: The COVID-19 pandemic presents significant future health challenges. Its impact on pregnant women and their newborn is a particular area of concern. This study aims to examine the potential role of maternal immune activation (MIA), due to SARS-CoV-2 infection, on early neurodevelopment. Methods: We analysed 107 mother-infant dyads from the COGESTCOV-19 study in Cantabria, Spain, which included 59 SARS-CoV-2 exposed (cases) and 48 unexposed (controls) mothers, recruited between December 2020 and February 2022. Cytokine levels (IL-6 and IL-10) were obtained from maternal blood and cord blood. Neurodevelopment was assessed using the Neonatal Behavioral Assessment Scale (NBAS) at six weeks of age. Trimester of infection was considered in the main analyses. Results: Results showed no significant overall delays in early neurodevelopment due to maternal SARS-CoV-2 infection. Control infants performed better in some NBAS items. However, cases infants showed trimester-specific differences. First-trimester exposure was related to motor and reflex delays, second-trimester to poorer performances in motor tasks and autonomic stability, and third-trimester to weaker state organization, regulation, and reflexes. Some correlations between cytokine levels and NBAS performance showed moderate associations. Conclusions: These findings highlight the need for ongoing neurodevelopmental monitoring of infants born during the COVID-19 pandemic. The study enhances our understanding of MIA's impact on early development, emphasizing the importance of addressing homeostatic mechanisms in mothers and newborns.http://www.sciencedirect.com/science/article/pii/S2666354625000146Maternal immune activation (MIA)SARS-CoV-2NeurodevelopmentCytokinesHomeostasisNeonatal behavioral assessment scale (NBAS)
spellingShingle Alexandre Díaz-Pons
Sergio Castaño-Castaño
Víctor Ortiz-García de la Foz
Ángel Yorca-Ruiz
Carlos Martínez-Asensi
Eva Munarriz-Cuezva
Rosa Ayesa-Arriola
Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance
Brain, Behavior, & Immunity - Health
Maternal immune activation (MIA)
SARS-CoV-2
Neurodevelopment
Cytokines
Homeostasis
Neonatal behavioral assessment scale (NBAS)
title Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance
title_full Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance
title_fullStr Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance
title_full_unstemmed Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance
title_short Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance
title_sort understanding the potential impact of trimester specific maternal immune activation due to sars cov 2 on early human neurodevelopment and the role of cytokine balance
topic Maternal immune activation (MIA)
SARS-CoV-2
Neurodevelopment
Cytokines
Homeostasis
Neonatal behavioral assessment scale (NBAS)
url http://www.sciencedirect.com/science/article/pii/S2666354625000146
work_keys_str_mv AT alexandrediazpons understandingthepotentialimpactoftrimesterspecificmaternalimmuneactivationduetosarscov2onearlyhumanneurodevelopmentandtheroleofcytokinebalance
AT sergiocastanocastano understandingthepotentialimpactoftrimesterspecificmaternalimmuneactivationduetosarscov2onearlyhumanneurodevelopmentandtheroleofcytokinebalance
AT victorortizgarciadelafoz understandingthepotentialimpactoftrimesterspecificmaternalimmuneactivationduetosarscov2onearlyhumanneurodevelopmentandtheroleofcytokinebalance
AT angelyorcaruiz understandingthepotentialimpactoftrimesterspecificmaternalimmuneactivationduetosarscov2onearlyhumanneurodevelopmentandtheroleofcytokinebalance
AT carlosmartinezasensi understandingthepotentialimpactoftrimesterspecificmaternalimmuneactivationduetosarscov2onearlyhumanneurodevelopmentandtheroleofcytokinebalance
AT evamunarrizcuezva understandingthepotentialimpactoftrimesterspecificmaternalimmuneactivationduetosarscov2onearlyhumanneurodevelopmentandtheroleofcytokinebalance
AT rosaayesaarriola understandingthepotentialimpactoftrimesterspecificmaternalimmuneactivationduetosarscov2onearlyhumanneurodevelopmentandtheroleofcytokinebalance